Trial · NCT07914114
The Efficacy of a Polarized Folded Optical Path-based Reading-writing Desk for Myopia Prevention and Control in Pre-myopic Children
NCT07914114, Not applicable, Not yet recruiting, Beijing Tongren Hospital
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Efficacy of a Polarized Folded Optical Path-based Reading-writing Desk for Myopia Prevention and Control in Pre-myopic Children. Trials, record NCT07914114. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07914114
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Efficacy of a Polarized Folded Optical Path-based Reading-writing Desk for Myopia Prevention and Control in Pre-myopic Children
- NCT number
- NCT07914114
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 200 participants, estimated
- Lead sponsor
- Beijing Tongren Hospital
- Conditions
- Pre-myopia
- Interventions
- Polarized folded optical path reading and writing device, Eye-care desk lamp and desk posture corrector
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Incidence of myopia | from baseline to 24±1 months | The proportion of participants who develop myopia during the follow-up period among those who were non-myopic at baseline. |
| Secondary | Change in Axial Length (AL) | baseline and 3, 6, 9, 12, 15, 18, 21, 24 months. | |
| Secondary | Change in accommodative lag | from baseline to 24±1 months | |
| Secondary | Change in Spherical Equivalent Refraction (SER) | baseline and 3, 6, 9, 12, 15, 18, 21, 24 months. | |
| Secondary | Change in NITM amplitude | from baseline to 24±1 months | |
| Secondary | Choroidal thickness | from baseline to 24±1 months | |
| Secondary | Incidence of myopic fundus changes | from baseline to 24±1 months | The proportion of participants who develop any of the following myopic fundus changes on color fundus photography during the follow-up period, among those without these changes at baseline: 1. tessellated fundus (visible choroidal vessels in the posterior pole), 2. optic disc tilt (tilt ratio ≤ 0.75), 3. peripapillary atrophy, 4. posterior staphyloma, 5. myopic maculopathy (META-PM Category ≥ 2). Participants with any one of these findings at any follow-up visit are counted as incident cases. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07914114
GET https://conductscience.org/api/trials/v1/NCT07914114/registered